Ellomay Capital Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $278.1M
- Price
- $20.18
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.84%
- Volume
- 632
About
Ellomay Capital Ltd., together with its subsidiaries, engages in the initiation, development, construction, and production of renewable and clean energy projects in Europe, the United States, and Israel. The company owns photovoltaic (PV) plants comprising five PV plants in Spain. It also engages in the operation of a dual-fuel operated power plant in Ashkelon, Israel; and construction of a hydro power plant in the Manara Cliff, Israel. In addition, it operates anaerobic digestion plants. The company was formerly known as NUR Macroprinters Ltd. and changed its name to Ellomay Capital Ltd. in April 2008. Ellomay Capital Ltd. was incorporated in 1987 and is headquartered in Tel Aviv-Yafo, Israel.
Quick stats
Shares outstanding13.8M
Computed float4.6M
Float / shares33.3%
Key info
SectorUtilities
IndustryRenewable Utilities
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000946394
Websitehttps://ellomay.com
AI Summary
AI-generated1/8
majormixedearnings
Ellomay Capital Reports Results for the Three and Six Months Ended June 30, 2026
Ellomay Capital reported a net profit of €58.3 million for the six months ended June 30, 2026, reversing a prior-year loss of €1.6 million, primarily due to a one-time gain of €83.3 million from the sale of its stake in Ellomay Luzon Energy.
However, continuing operations deteriorated to a loss of €25 million, widening from a €1.6 million loss in the prior year, largely driven by foreign exchange losses of €24.7 million resulting from the appreciation of the NIS against the euro.
Despite the operational FX loss, the company strengthened its balance sheet with total assets rising to €959.2 million and net financial debt decreasing to €50.9 million, maintaining compliance with all financial covenants.
Red flags
- Loss from continuing operations widened to €25 million from €1.6 million year-over-year
- Significant foreign exchange volatility caused €24.7 million in financing expenses
- Regulatory uncertainty in the USA prevents management from providing forecasts